DIEGO PEDROZA to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications DIEGO PEDROZA has written about Xenograft Model Antitumor Assays.
Connection Strength
0.286
-
Leveraging preclinical models of metastatic breast cancer. Biochim Biophys Acta Rev Cancer. 2024 09; 1879(5):189163.
Score: 0.189
-
Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
Score: 0.049
-
CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 2024 Sep 17; 9(20).
Score: 0.048